Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone.
Rodney Daniel SinclairPublished in: International journal of dermatology (2017)
Once daily capsules containing minoxidil 0.25 mg and spironolactone 25 mg appear to be safe and effective in the treatment of FPHL. Placebo-controlled studies to investigate this further are warranted.